# Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis

> **NCT03755245** · NA · ENROLLING_BY_INVITATION · sponsor: **Turku University Hospital** · enrollment: 26 (estimated)

## Conditions studied

- Healthy Subjects
- Rheumatoid Arthritis
- Vasculitis
- Pulmonary Sarcoidosis

## Interventions

- **OTHER:** [68Ga]Ga-DOTA-Siglec-9

## Key facts

- **NCT ID:** NCT03755245
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2018-11-23
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2024-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03755245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03755245, "Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03755245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*